Although breast-cancer screening programmes are now being introduced it is still debated whether this is an appropriate policy for all European countries.
Taking into account empirical data from 2 regional pilot screening projects, this study has evaluated the effects and costs of a nationwide breast-cancer screening programme in Germany.
Special attention was paid to the decentralized German health-care system and to the influence of attendance, interval and age group.
The recent results of the analgsis of the Swedish randomized screening trials were used to estimate the improvement in prognosis after early detection of breast cancer.
Mots-clés Pascal : Tumeur maligne, Glande mammaire, Dépistage, Allemagne, Europe, Coût, Economie santé, Homme, Glande mammaire pathologie
Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Medical screening, Germany, Europe, Costs, Health economy, Human, Mammary gland diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0645191
Code Inist : 002B20E02. Création : 09/06/1995.